Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab
- PMID: 18246698
Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab
Abstract
Primary cutaneous infection with Cryptococcus neoformans is uncommon, but can occur following an inoculation injury to the skin. Tumor necrosis factor-alpha (TNF-alpha) is important in the immune response to Cryptococcus, and patients taking inhibitors of TNF-alpha may have increased susceptibility to cryptococcal infection. We report a case of primary cutaneous cryptococcosis in a patient taking adalimumab, methotrexate, and hydroxychloroquine for rheumatoid arthritis.